Articles tagged with Probiotics
A review of 13 randomized controlled trials found that only Bifantis showed significant improvement in IBS symptoms. The study evaluated the safety, efficacy, and tolerability of probiotics for IBS treatment.
Researchers found that combining Lactobacillus rhamnosus GG probiotic strain with lower doses of hyperimmune bovine colostrum (HBC) provides protection against rotavirus infection, effective as high-dose HBC alone. This combination therapy could help relieve the immense disease burden posed by rotavirus in developing countries.
Scientists discover probiotics can reduce Salmonella bacteria in pigs, potentially cutting food poisoning cases. The new technique uses 3D models to test probiotic effects without live animals.
Researchers found that Bifantis delayed the onset of artificially induced arthritis and resulted in less severe arthritic symptoms. In a second study, Bifantis increased the numbers of immune cells controlling the response to harmful pathogens like Salmonella, limiting inflammation.
Researchers found that probiotics reduced the risk of necrotising enterocolitis in premature babies by 64% and the risk of death by 53%. The study also showed a significant reduction in sepsis risk and an average delay of three days in achieving full feeds. Further trials are needed to confirm these results.
A recent survey reveals that almost half of US adults have never heard of probiotics, but many show interest in trying them due to intestinal health concerns. The study highlights the growing awareness and potential benefits of probiotic supplements in preventing and managing gastrointestinal issues.
The task force identified rapidly expanding research on vitamin D's benefits beyond bone health, as well as growing interest in nutrient-dense foods. Probiotics and prebiotics were also discussed for their intestinal and immune health benefits.
Researchers found that probiotic bacteria can prevent the 'leakiness' of the gut wall and reduce bacterial adherence to cells, alleviating symptoms of irritable bowel syndrome and inflammatory bowel disease. Probiotics offer a promising approach to managing intestinal problems caused by chronic stress.
A recent study found that daily probiotic supplements reduced sick days among workers. The study, which involved 181 staff members, showed that workers taking L. reuteri probiotics reported significantly fewer sick days compared to those taking a placebo.
A novel probiotic strain, B. infantis 35625, shows promise in normalizing bowel movement frequency in IBS patients. Researchers found modest improvement in bloating symptoms, but emphasize the need for larger trials to verify findings.
Researchers at Baylor, MIT and Hebrew University have made significant progress in understanding the potential of combination therapy for Inflammatory Bowel Disease (IBD). Probiotics and commensal bacteria have been shown to modulate mucosal pro-inflammatory cytokine production and reduce symptoms in mice. Additionally, a new class of ...
A new clinical study examines whether restoring good bacteria in intensive-care patients can help prevent infections. The study, led by Dr. Robert G. Martindale, aims to enroll 400 patients and assess the effectiveness of probiotics in reducing infections.
Researchers have found that bacterial DNA from probiotics can reduce inflammation in mice with experimental colitis. The study discovered that purified probiotic DNA activates a specific element within the innate immune system, which helps to slow down inflammation.
A UCSD study found that inactivated probiotics can effectively alleviate colitis in mice, suggesting a new approach to IBD treatment. The study also identified the innate immune system as a key player in the beneficial effects of probiotics.
Researchers found that early exposure to probiotics Lactobacillus GG reduced the risk of atopic eczema by 40% in children at four years old. The study suggests a potential preventive effect against eczema in infancy and childhood.
A multi-center study found that 63% of patients with mild to moderate ulcerative colitis achieved remission after taking four packets of VSL#3 daily for six weeks. The probiotic composition demonstrated safety and efficacy in patients not responding to conventional therapies.